Coleen Glessner - Apr 7, 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Quality & Ethics, and CPL
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Apr 7, 2025
Transactions value $
-$2,131
Form type
4
Date filed
4/9/2025, 06:35 PM
Previous filing
Mar 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$2.13K -480 -0.27% $4.44 176K Apr 7, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units